Although the development of most vaccines against coronavirus infection is only (was only one Russian vaccine – Sputnik V), a pharmaceutical company has already concluded with the governments of various countries, contracts for the supply of vaccines in case of their successful studies. Currently, the pre-order feature approximately 5.7 billion doses, according to MedicalXpress.
At present, five vaccines (the three Western pharmaceutical companies and two Chinese developers) are in the clinical study phase III with the participation of several thousand volunteers. 11 August it became known about registration of Russian vaccine against the coronavirus that causes the Satellite V is the first regulator approved a similar drug in the world.
The first agreement pre-order vaccines began to enter into the USA, now these contracts are signed with companies of Johnson & Johnson, Moderna, Oxford/AztraZeneca, Novavax, Pfizer/BioNTech, Sanofi/GSK, Merck Sharp and Dohme. All of US hope to get a pre-order of 700 million doses of vaccines.
Another 700 million doses ordered, the EU authorities have Oxford/AztraZeneca and Sanofi/GSK, both companies expect to receive the results of studies of their vaccines already in the autumn of this year. Because of Brexit Britain is compelled to agree to supply vaccines, the relevant agreements on the delivery of 250 million doses achieved with 4 producers.
Also the pre-order has issued, the government of Japan (490 million doses), Brazil (100 million doses) and China. According to Russian officials, domestic vaccine Sputnik V interested in 20 countries, and for pre-order sold 1 billion doses of vaccine.